A new variant of COVID-19, known as XEC, is beginning to spread

 

A new COVID-19 variant, XEC, is starting to spread and could potentially become the dominant strain, according to scientists. First identified in Germany in June, cases of XEC have now been reported in the UK, US, Denmark, and other countries, as noted by users on X (formerly Twitter).

The variant carries mutations that might increase its transmission this autumn, though vaccines are expected to continue preventing severe illness. For those at higher risk of serious illness from COVID-19, the NHS offers a free booster shot. These vaccines have been updated to target recent variants, though not specifically XEC, which evolved from earlier Omicron subvariants.

Professor Francois Balloux, Director of the Genetics Institute at University College London, told the BBC that while XEC has a "slight transmission advantage" over other variants, vaccines should still offer good protection. He added that XEC might become the dominant subvariant over the winter.

Eric Topol, Director of the Scripps Research Translational Institute in California, stated that XEC is "just getting started" and could take weeks or months to cause a significant wave of cases. "XEC is definitely taking charge," he told the LA Times, although it could be some time before it reaches high levels.

Symptoms of XEC
The symptoms of the XEC variant are thought to be similar to earlier strains of COVID-19, such as:

• High temperature
• Aches
• Tiredness
• Cough or sore throat

Most people recover within a few weeks, but some may experience a longer recovery time.

According to COVID data analyst Mike Honey, XEC has shown "strong growth" in Denmark and Germany. However, due to reduced routine testing, it's challenging to determine the full extent of its spread.

The UK Health Security Agency (UKHSA) reminds the public that viral mutations are normal. The main vaccination campaigns for flu and COVID-19 will begin in October, though some people may receive their shots earlier. Those eligible for a free booster vaccine include:

• Adults aged 65 and over
• Residents in care homes for older adults
• Individuals over six months in clinical risk groups
• Some frontline NHS, care-home, and social-care workers

Dr. Gayatri Amirthalingam, Deputy Director at UKHSA, emphasized the importance of vaccination in providing the best protection against serious illness from COVID-19.